Skip to main content
Fig. 3 | BMC Bioinformatics

Fig. 3

From: Systematic analysis identifies XRCC4 as a potential immunological and prognostic biomarker associated with pan-cancer

Fig. 3

Survival analysis with high and low YTHDF1 expression. A–C Kaplan–Meier analysis of the association between XRCC4 expression and OS, DFS and RFS in KIRC analyzed by the GEPAI database and the Kaplan–Meier plotter database, D, E Kaplan–Meier analysis of the association between XRCC4 expression and DFS (D) and RFS (E) in STAD analyzed by the GEPAI database and the Kaplan–Meier plotter database, respectively, F–K Kaplan–Meier analysis of the association between XRCC4 expression and OS in BRCA (F), UCEC (G), LUAD (H), THYM (I), LIHC (J), and PRAD (K); L, M Kaplan–Meier analysis of the association between XRCC4 expression and DFS in KICH (L) and LGG (M); O, P Kaplan–Meier analysis of the association between XRCC4 expression and RFS in KIRP (L) and HNSC (O); The red line represents high XRCC4 expression and the blue line represents low XRCC4 expression. OS, overall survival; PFI, progression-free interval; DSS, disease-specific survival

Back to article page

BMC Bioinformatics

ISSN: 1471-2105

Contact us